Elekta shares rise on Q4 EBIT, sales beat

Elekta AB (publ)

28/05/2025 08:40

** Shares in Elekta EKTAb.ST rise nearly 5% after the Swedish radiation therapy equipment maker reported Q4 EBIT, sales beat

** Q4 Adjusted EBIT rises 29% y/y to SEK 843 million ($87.5 million), 12% above consensus, and Q4 sales at SEK 5.2 bln (1% above consensus)

** For FY 2025/26 company is expecting net sales to improve, margins to expand with EBIT progressing towards the 14% mid-term target

** J.P.Morgan calls Elekta's Q1 guidance as 'largely qualitative'

** Elekta AB is among top performers on STOXX 600 .STOXX index

($1 = 9.6281 Swedish crowns)

 (Reporting by Agnieszka Gosciak-Rabalska)

 ((Agnieszka.gosciak@thomsonreuters.com))